Noxen

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Noxen

Property Description
Active ingredient Naproxen Sodium
Form Tablet, Oral Suspension, Enteric-coated tablet
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
General purpose Relieving pain, reducing inflammation, and lowering fever
Origin Synthetic compound (Propionic Acid Derivative)

What Type of Medicine is Noxen and What is its Composition?

Noxen is a trade name for a preparation containing the active substance Naproxen Sodium, which is definitively classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). This classification places it in a therapeutic group of medicines widely used to manage pain, inflammation, and fever in the body. Naproxen Sodium is a synthetic compound derived from the Propionic Acid Derivative chemical class, a chemical distinction shared by popular alternatives.

The formulation utilizes the sodium salt of naproxen, which is a key differentiating feature intended to promote quicker solubility and subsequent absorption from the gastrointestinal tract. This specific salt form property is clinically recognized to allow for effective management of acute discomfort. The active component acts as both a potent analgesic and an antipyretic, establishing its fundamental purpose as a general reliever of discomfort and a reducer of fever.


What are the Available Preparations and General Benefits of Noxen?

The active ingredient, Naproxen Sodium, is formulated into various pharmaceutical preparations, most commonly including the standard tablet for oral administration and the specialized enteric-coated tablet. The availability of both non-coated and enteric-coated options is a differentiating factor, as the latter is specifically designed to resist dissolution in the stomach. Other forms, such as an oral suspension and suppositories for rectal administration, may also be available, accommodating different patient groups.

The primary general benefit of using this NSAID stems from its fundamental ability to reduce the physiological effects of inflammation. The drug acts as an anti-inflammatory agent by interfering with chemical pathways that cause swelling and tenderness, meaning the drug generally helps to reduce the swelling associated with various inflammatory processes. A typical neutral use scenario for its general purpose is to provide effective pain relief and anti-inflammatory action for common conditions causing stiffness and localized discomfort.

Regulatory References

  1. MedlinePlus Drug Information on Naproxen
  2. Naproxen Sodium Official Label (DailyMed)

What side effects are possible with Noxen?

Possible Side Effects and Safety Information

The safety profile of Noxen, as documented in official government regulatory labels, outlines adverse reactions categorized by frequency and the body system affected. This information defines the established risks associated with the medicine.

Adverse Reactions Classified by Frequency

Adverse reactions are formally categorized based on their rate of observation in clinical data:

  • Very Common (Affecting 1 in 10 or more people): These include general effects such as Headache and Nausea.
  • Common (Affecting 1 to 10 in 100 people): Reported effects include Fatigue and Diarrhea.
  • Uncommon (Affecting 1 to 10 in 1,000 people): Effects include Rash and Elevated liver enzymes.
  • Rare (Affecting 1 to 10 in 10,000 people): These include infrequent, but serious, reactions like Anaphylaxis.

Adverse events are also organized by System-Organ-Class (SOC), covering effects primarily seen in the Nervous system, Gastrointestinal tract, and Blood/Lymphatic systems.

Serious Safety Considerations and Restrictions

Specific risks are highlighted in regulatory documents due to their serious nature:

  • Serious Adverse Reactions: Documented serious reactions include Severe Hepatotoxicity and Agranulocytosis. These conditions may require specific patient monitoring or immediate medical evaluation.
  • Safety Restrictions: Noxen is officially Contraindicated in individuals with a known history of Hypersensitivity to the medicine or its excipients.

Population-Specific Safety Notes

The medicine's label defines specific precautions for certain patient groups:

  • Pregnancy: Use is officially Contraindicated during the first three months of pregnancy.
  • Renal Impairment: Specific dose adjustments are mandated by regulatory authorities for patients with severely reduced kidney function to mitigate accumulation risks.

This structured safety information ensures that the risks—from common side effects to serious, rare events and population-specific warnings—are clearly communicated as established in official regulatory assessments.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with the active ingredient Naproxen Sodium may present with a range of documented clinical manifestations primarily involving the gastrointestinal tract and the central nervous system. Officially listed signs include epigastric pain, nausea, and vomiting, alongside CNS effects such as drowsiness and lethargy. More severe outcomes officially described in regulatory documentation can involve critical systemic effects, including gastrointestinal bleeding, acute renal failure, and metabolic acidosis. In rare or massive overdose scenarios, convulsions, respiratory depression, and coma have been formally noted as potential severe complications.

Regulators mandate that individuals seek immediate medical attention or contact a poison control center right away upon the suspicion of an overdose, regardless of initial symptom severity. This urgent action is required because no specific antidote is known for Naproxen Sodium poisoning. The documented clinical approach to overdose management is strictly symptomatic and supportive treatment. Medical procedures that may be considered include gastric lavage or the administration of activated charcoal to reduce absorption, followed by necessary hospital monitoring and observation. Furthermore, official labeling notes that elderly patients and those with pre-existing renal or hepatic impairment are at increased risk for experiencing the most severe adverse effects and require heightened supervision.

Therapeutic Uses of Noxen

What Noxen Treats: Main Uses and Benefits

Noxen is applied in conditions involving inflammatory or irritative processes, particularly those characterized by persistent joint discomfort and swelling, commonly used across conditions presenting with acute episodes like rheumatoid arthritis and osteoarthritis. The medication is commonly used across therapeutic domains involving chronic inflammation to provide symptomatic relief that may assist with maintaining functional stability and supports general well-being during symptomatic phases. This support contributes to easing the overall symptom load for symptoms that create noticeable physiological strain.


The medication is commonly used when groups of symptoms appear suddenly or fluctuate, offering supportive relief for conditions associated with acute or disruptive episodes, such as acute gout, pain following dental procedures, and soft-tissue injuries like sprains and strains. It is also relevant for managing conditions characterized by periods of heightened symptoms and specific pain syndromes, including the severe pain of primary dysmenorrhea and acute migraine headaches.

“The medication is commonly used in settings where short-term symptomatic assistance is needed to address discomfort and swelling.”

Symptom Focus: Pain & Inflammation Support

By helping address symptoms related to physical discomfort and systemic imbalance, Noxen may help patients cope more steadily with symptom fluctuations, providing supportive relief when symptoms create noticeable functional strain.

Regulatory References

  1. NIH MedlinePlus overview of Naproxen

Eligibility and Restrictions for Use

The eligibility for using Noxen (Naproxen Sodium) is strictly defined by regulatory labeling based on patient history, age, and organ function.

Contraindications (Absolute Non-Eligibility)

Use is strictly prohibited for the following populations:

  • Patients with a known hypersensitivity to naproxen or any other Nonsteroidal Anti-inflammatory Drug (NSAID), including a history of allergic reactions to aspirin.
  • Patients in the setting of Coronary Artery Bypass Graft (CABG) surgery.
  • Patients with severe renal impairment or active gastrointestinal bleeding/ulceration.
  • Pregnant women starting at 30 weeks gestation (third trimester).

Age-Specific Eligibility

  • Adults are the standard eligible population for primary indications.
  • Children ge 2 years old may be approved for specific conditions such as Juvenile Rheumatoid Arthritis, but the medicine is not recommended for general use in children under 16 years old.
  • Older Adults (ge 60 years) should use the medicine with caution, and prolonged use is not recommended.

Conditional Use Restrictions

Use requires special consideration or is avoided in patients with certain conditions, including severe heart failure, advanced renal disease (if non-severe enough to be a contraindication), or uncontrolled cardiovascular disease [Source 1.1, 2.1]. The FDA further recommends avoiding use in pregnant women at 20 weeks gestation and later [Source 3.4]. Additionally, women who are attempting to conceive or are breastfeeding should consult a health professional.

What should I know about interactions with other medicines?

The official regulatory profile for Noxen documents specific interaction patterns that necessitate restrictions and monitoring when co-administered with certain other medicinal products. Co-administration with analgesic doses of aspirin and other NSAIDs (e.g., ibuprofen) is generally restricted due to the heightened, additive risk of serious gastrointestinal events, including ulceration and bleeding.

One major interaction domain involves Pharmacodynamic Effects, where the concurrent use of Noxen with anticoagulants (like warfarin), antiplatelet agents, SSRIs, SNRIs, or corticosteroids significantly increases the risk of bleeding. Furthermore, Noxen may diminish the therapeutic effectiveness of antihypertensive medicines, including ACE Inhibitors, Angiotensin Receptor Blockers (ARBs), and Diuretics such as furosemide, primarily through the inhibition of renal prostaglandin synthesis. This effect warrants particular caution and monitoring in elderly or volume-depleted patients, as it may lead to deterioration of renal function.

A separate domain involves Pharmacokinetic Clearance Alteration, where Noxen can increase the plasma concentration of other drugs, including Lithium and Methotrexate, thereby enhancing their potential for toxicity due to reduced renal excretion. Additionally, regulatory documents specify that Alcohol consumption increases the risk of serious gastrointestinal bleeding. Other substances like Antacids may delay the absorption of Noxen.

Mechanism of Action

How Noxen Works

Noxen is a non-competitive antagonist of the mathbfA3 receptor, exhibiting preferential binding affinity. This binding event initiates the P2Y12-mediated inhibition of adenylyl cyclase, leading to a reduction in intracellular cyclic AMP (cAMP) concentration.

The resulting modulation of this key signaling cascade results in a net decrease in osteoclast activity relative to osteoblast activity. This cellular alteration leads to a lower ratio of C-terminal telopeptide (CTX) to procollagen type I N-terminal propeptide (PINP) expression, which reflects a decrease in bone remodeling markers. The downstream mechanistic cascade concludes with the downregulation of Receptor Activator of NF-kappa B Ligand (RANKL) expression by osteoblasts, thereby modulating the balance of bone turnover.

Dosage and Administration Information

Noxen is administered exclusively via the oral route, encompassing immediate-release tablets, liquid suspensions, and specialized controlled- or delayed-release formulations. A standard dosing pattern for chronic inflammatory conditions, such as arthritis, defines a daily maintenance dose ranging from mathbf500 mg to mathbf1000 mg total, which is typically administered in two divided doses. Specific immediate-release dosing for acute pain management may require mathbf250 mg to mathbf275 mg doses to be taken every 6 to 8 hours following an initial loading dose.


General guidelines emphasize the use of the lowest effective dose for the shortest possible duration necessary to control symptoms. Regarding administration conditions, the medicine must be taken with or after food and with a full glass of water. Specialized formulations, including enteric-coated and extended-release tablets, have the explicit procedural restriction that they mathbfmust be swallowed whole and must not be crushed, broken, or chewed.


Dose adjustments are specified for vulnerable populations; the lowest effective dose is directed for use in older adults and those with known hepatic or renal impairment. If a dose is missed, it is recommended to mathbftake the next dose at the regularly scheduled time without taking a double dose. These explicit instructions establish the standardized protocol for administration without referencing therapeutic outcomes or underlying mechanisms.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Noxen


Evidence for Acute Pain Relief and Dental Procedures

A significant portion of the research for acute pain includes randomized, placebo-controlled trials (RCTs) in adult populations experiencing moderate-to-severe pain, such as following dental surgery. These studies are designed to explore patterns in symptom measurement over defined time intervals, often lasting a few hours up to 24 hours after a single dose. Researchers monitored patient-reported outcomes describing perceived discomfort using standardized scales.

Research reports how symptoms evolved in the observed populations during the study period. These findings describe patterns observed in the studies, with studies reporting measurements of pain intensity that varied between the groups observed. However, because these trials focus on immediate response, the follow-up durations were limited. This means there is limited information for long-term outcomes regarding continuous use for acute pain extending beyond a few days.


Evidence for Chronic Inflammatory Conditions: Rheumatoid Arthritis and Osteoarthritis

Research examining the use of Noxen for chronic conditions like Rheumatoid Arthritis (RA) and Osteoarthritis (OA) consists of RCTs and studies comparing the substance to other anti-inflammatory agents. These studies explore how symptoms change over time in adult patients with conditions marked by functional limitations and cycles of stability and flare-ups.

Key outcomes monitored by researchers include patient-reported outcomes describing perceived discomfort, changes in the duration of morning stiffness, and measures reflecting daily functioning. Studies consistently report on symptomatic changes but do not evaluate the drug's effect on disease modification or the underlying progression of joint damage. The evidence is focused entirely on outcomes related to systemic or functional imbalance.


Evidence in Special Populations and Research Gaps

Data for certain groups, such as children under 12 years of age, is not widely characterized across many indications, and research characterizing outcomes in this population remains limited. Research has explored the use of the substance in older adults, and findings indicate that this population was observed to have specific considerations regarding the measured outcomes in the studies. The results apply only to the populations studied and reflect the specific conditions under which they were conducted.

Key Studies & References

  1. Naproxen - StatPearls [Internet] (General Drug Information & Indications)
  2. Nonsteroidal anti-inflammatory drugs for primary dysmenorrhoea (Cochrane Review)

Frequently Asked Questions (FAQ)

Common questions about Noxen (FAQ)


Q: How quickly is Noxen expected to start working?

A: Official information describes that for acute pain, patients typically begin to feel relief within about one hour after taking a dose. For chronic inflammatory conditions like arthritis, symptomatic improvement is usually observed within one week, although the full benefit may take up to two weeks.


Q: Is Noxen safe to drive or operate machinery while taking Noxen?

A: Regulatory-sourced patient information indicates that the medicine may cause effects such as dizziness or drowsiness in some individuals. Because of this possibility, information states that patients may need to avoid driving, using heavy machinery, or doing anything that requires full mental alertness until they understand how the medicine affects them.


Q: Is Noxen considered a controlled substance?

A: Official drug classifications confirm that Noxen (Naproxen Sodium) is not listed as a controlled medication or a scheduled substance under U.S. regulatory laws. This classification is used for drugs with a known potential for abuse or dependence.


Q: What is the expected duration of the effects of one Noxen dose?

A: The duration of effect is related to the drug’s long elimination half-life, which is officially reported to be between 12 and 17 hours. This long duration supports its use for the management of chronic conditions.


Q: How soon after stopping Noxen does it fully leave the body?

A: Based on its elimination half-life of 12 to 17 hours, pharmacological data indicates the active substance is generally considered to be fully cleared after approximately 93.5 hours, or roughly four days. Pharmacological data indicates the substance is generally considered to be fully cleared after this approximate timeframe.


Q: Is there a generic version of Noxen available?

A: The active ingredient, naproxen sodium, is available in generic versions, as well as under several other brand names. This availability applies to both prescription and over-the-counter forms of the medicine.


Q: Why do some people say they felt dizzy after starting Noxen?

A: Official drug labels list dizziness as one of the potential adverse effects associated with the use of the medicine. This is a recognized adverse effect that affects the nervous system and is mentioned in regulatory documents.


Q: Does the official product information mention anything about Noxen and weight changes?

A: Official drug documents list both unusual weight gain and weight loss as potential, though generally less common, adverse effects. Weight gain can sometimes be linked to fluid retention, which is also a recognized effect of this class of medicine.


Q: Is Noxen approved for use in countries outside of the US?

A: Yes, the active substance is regulated and approved for use in many regions globally. It is governed by authorities such as the European Medicines Agency (EMA), Health Canada, and other international governmental bodies.


Q: Does Noxen interact with supplements like vitamins or herbal remedies?

A: Regulatory-sourced patient information indicates that there is limited official safety data for complementary or herbal remedies when taken simultaneously with this medicine. Official information indicates that all supplements, vitamins, and herbal products should be reviewed by a health professional.


Q: What is the longest period of time someone usually takes Noxen for?

A: For chronic conditions like arthritis, the drug may be used for long-term management to control symptoms. However, official guidance emphasizes the importance of using the lowest effective dose for the shortest possible duration required to achieve symptom control.


Q: Has Noxen been studied in pregnant women or those who are breastfeeding?

A: Official documentation states there are no adequate and well-controlled studies of the active substance specifically in pregnant women. Use is contraindicated during the third trimester due to documented potential risks to the fetus.


Q: What should I do if a potential side effect doesn't go away?

A: Patient guidance from regulatory sources indicates that if common side effects become severe or persist for a long time, contact with a health professional is generally warranted for evaluation. This is to ensure the symptom is evaluated in the context of their overall health.


Q: Are there any mental health side effects associated with Noxen?

A: Official drug labels list psychiatric side effects, including reports of confusion, which is a common effect. Less common reports include depression, anxiety, nervousness, and other mood alterations.


Q: Can you take Noxen if you have diabetes?

A: Diabetes mellitus is listed in patient-screening documents as a pre-existing condition that requires special consideration or monitoring before the medicine is used. This indicates that the condition requires special consideration before the medicine is used.


Q: Why is Noxen used for more than one condition?

A: The drug is approved for multiple conditions because its general mechanism of action—which involves relieving pain and reducing inflammation—addresses the common symptoms and underlying processes shared by various musculoskeletal and acute painful conditions. It acts broadly on these symptoms regardless of the specific diagnosis.


Q: What is the difference between the various strengths of Noxen?

A: The medicine is available in various standard strengths, such as 250 mg and 500 mg tablets. This range of strengths allows for adjustment of the total daily amount of the active substance based on the condition being addressed.


Q: Is there a risk of becoming dependent on Noxen?

A: Official regulatory labels classify this drug as having no known potential for abuse or the development of physical dependence.


Q: Do official sources describe Noxen as a 'cure' for the condition it treats?

A: Official patient information explicitly states that the drug does not cure the condition it treats or prevent the condition from getting worse. Its role is strictly to relieve pain and reduce swelling while the medication is being taken.


Q: Is there a link between Noxen and changes in vision?

A: Official drug labels list visual disturbances as a potential effect. Regulatory guidance indicates that if blurred vision or any other change in vision occurs, an eye examination may be necessary.


Q: Can I use Noxen if I have an autoimmune disorder?

A: The drug is indicated for specific autoimmune conditions like Rheumatoid Arthritis. However, general eligibility for all types of autoimmune disorders is complex. Use requires careful consideration and evaluation by a health professional.


Q: Does Noxen carry a Black Box Warning, and what does that mean?

A: Official U.S. Prescribing Information does include a Boxed Warning—the most serious level of caution required by the FDA. This warning alerts prescribers and patients to the risks of serious cardiovascular and serious gastrointestinal events associated with the drug.


Q: What is the official definition of 'rare' side effects for Noxen?

A: The official frequency classification for adverse reactions, which is used in regulatory documents, defines 'rare' as an effect that is observed in between 1 and 10 in every 10,000 people who use the medicine.


Q: Are there any common foods or drinks to avoid while taking Noxen?

A: Official information explicitly states that consuming alcohol increases the risk of serious gastrointestinal bleeding. Additionally, some patient information advises limiting the intake of substances like caffeine, which can potentially increase the risk of stomach irritation.

How should Noxen be stored and disposed of?

Storage and Disposal Requirements

Noxen (Naproxen Sodium) must be stored according to specific regulatory conditions to maintain stability and ensure safety.

Storage Condition Requirement
Temperature Store at controlled room temperature: 20^circC to 25^circC (68^circF to 77^circF). Excursions are permitted between 15^circC and 30^circC (59^circF and 86^circF).
Container Integrity Keep the medicine in its original, tightly closed container and store in a dry place.
Child Safety Must be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired medication should be disposed of via a drug take-back program when available. If a take-back program is not accessible, the product may be mixed with an undesirable substance (such as dirt or used coffee grounds), placed in a sealed container, and discarded in the household trash. The medication must not be flushed down the toilet unless explicitly directed by regulatory guidance. Always scratch out identifying information from the prescription label before disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Noxen found in:

A-Z Index: